Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BDR LIFESCIENCES PRIVATE LIMITED has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. CHAO, ALLEN is the busiest examiner, managing 1 pending action.
The portfolio's active prosecution is limited to 1 pending office action. Since there is 1 distinct examiner, CHAO, ALLEN is the only official currently reviewing the company's patent applications. The presence of 1 distinct art unit indicates that the company's current legal activity is focused within a single technical examination group.
For a practitioner, this concentration means that the prosecution strategy is entirely dependent on the interpretation of CHAO, ALLEN. There are no other active matters to provide a baseline for examiner behavior within this portfolio. The focus within the art unit implies that the technical subject matter is restricted to a specific niche. Success in this matter will require a deep understanding of the assigned examiner's specific requirements and the art unit's internal standards for the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHAO, ALLEN | 1 | 60.0% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18854748 | Novel Process and Intermediate for the Preparation of Apalutamide | CHAO, ALLEN | 1622 | §102 | Non-Final OA | — | Pending | Oct 07, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBDR LIFESCIENCES PRIVATE LIMITED has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Allen Chao has the most, with 1 of BDR LIFESCIENCES PRIVATE LIMITED's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.